{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:34:40Z","timestamp":1790472880677,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.antiviral.2007.08.003","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T07:24:06Z","timestamp":1188977046000},"page":"39-49","source":"Crossref","is-referenced-by-count":99,"title":["Efficacy of therapeutic intervention with an oral ether\u2013lipid analogue of cidofovir (CMX001) in a lethal mousepox model"],"prefix":"10.1016","volume":"77","author":[{"given":"Scott","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Touchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Oberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrick","family":"Almond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.08.003_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3181\/00379727-122-31255","article-title":"Human influenza resulting from aerosol inhalation","volume":"122","author":"Alford","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2007.08.003_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"58","author":"Bray","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(01)00220-0","article-title":"Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir","volume":"54","author":"Bray","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"Buller","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.08.003_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6822(92)90445-U","article-title":"Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene","volume":"187","author":"Chen","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2007.08.003_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib8","first-page":"19","article-title":"Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections","volume":"58","author":"De Clercq","year":"1996","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"10.1016\/j.antiviral.2007.08.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib10","series-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.antiviral.2007.08.003_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.antiviral.2007.08.003_bib12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0006-2952(97)82446-X","article-title":"Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro","volume":"53","author":"Hostetler","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2007.08.003_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.antiviral.2006.10.009","article-title":"Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice","volume":"73","author":"Hostetler","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.08.003_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.08.003_bib15","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/AAC.48.5.1869-1871.2004","article-title":"Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro","volume":"48","author":"Keith","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.08.003_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.08.003_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/infdis\/171.4.788","article-title":"(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I\/II study of a novel antiviral nucleotide analogue","volume":"171","author":"Lalezari","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.08.003_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0507-517","article-title":"Dramatic rescue relieves rare case of smallpox infection","volume":"13","author":"Marris","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2007.08.003_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/374054","article-title":"Can postexposure vaccination against smallpox succeed?","volume":"36","author":"Mortimer","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.08.003_bib20","series-title":"Current Protocols in Molecular Biology","article-title":"Expression of proteins in mammalian cells using vaccinia cirus vectors. Overview of the vaccinia virus expression system","author":"Moss","year":"1998"},{"key":"10.1016\/j.antiviral.2007.08.003_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.12.1.62-68.1975","article-title":"Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus","volume":"12","author":"Murphy","year":"1975","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2007.08.003_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2007.08.003_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.00879-06","article-title":"Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.08.003_bib24","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/AAC.47.10.3275-3280.2003","article-title":"Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice","volume":"47","author":"Quenelle","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.08.003_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.08.003_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.08.003_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0","article-title":"Clinical uses of cidofovir","volume":"7","author":"Safrin","year":"1997","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2007.08.003_bib28","series-title":"Bulletin of the World Health Organization","article-title":"Virus excretion in smallpox 1","author":"Sarkar","year":"1973"},{"key":"10.1016\/j.antiviral.2007.08.003_bib29","first-page":"41","article-title":"Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL\/6j, BALB\/cByj and AKR\/J inbred mice","volume":"35","author":"Wallace","year":"1985","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.antiviral.2007.08.003_bib30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2007.08.003_bib31","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207003956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207003956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T05:06:35Z","timestamp":1587877595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207003956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0166354207003956"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.08.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}